Lee Jae-yong's 'Propofol Administration Allegation' First Trial Postponed Again to the 12th of Next Month

Lee Jae-yong, Vice Chairman of Samsung Electronics / Photo by Jinhyung Kang aymsdream@

[Asia Economy Reporter Kim Daehyun] The first trial of Samsung Electronics Vice Chairman Lee Jae-yong, who was indicted on charges of illegally administering propofol, has been postponed again.

According to the legal community on the 6th, Judge Jang Young-chae of the Seoul Central District Court Criminal Division 11, who is presiding over the case, changed Lee's first trial date, originally scheduled for the 7th, to the 12th of next month. This is the second time Lee's trial date for this case has been delayed. The court had also postponed the initially scheduled first trial date to this day last month.

Previously, Lee was investigated after a public interest report was filed with the Anti-Corruption and Civil Rights Commission alleging that he habitually administered propofol, a psychotropic drug, at a plastic surgery clinic in Gangnam, Seoul. The prosecution filed a summary indictment on July 4th, judging that he administered propofol for non-medical purposes.

Subsequently, the prosecution received another propofol-related case involving Lee from the police, launched an investigation, and requested the court to refer the case to a formal trial procedure. At that time, a prosecution official stated, "We applied for a formal trial procedure to review the necessity of amending the indictment based on the results of the ongoing investigation of similar cases." The court accepted the prosecution's request and referred the case to a formal trial.

Lee will face another trial following the ongoing trial related to 'unfair merger and accounting fraud.'

This content was produced with the assistance of AI translation services.